JOHNNY BALL: Open Payments
NPI 1902532930 · SMITHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 28 payments from 11 companies in 2025. Trend: 2023 $238 · 2024 $261 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $112 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Medtronic, Inc. | 3 | $55 |
| Exact Sciences Corporation | 3 | $54 |
| Novo Nordisk Inc | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| ABBVIE INC. | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Ascendis Pharma Endocrinology Inc | 1 | $21 |
Products named: CAPLYTA, MINIMED 780G, Cologuard Collection Kit, REXULTI, Ozempic, FARXIGA, VRAYLAR, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
